ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Assessing the Public Health Benefit of a mRNA-Based Respiratory Syncytial Virus Vaccine (mRNA-1345) Among Adults ≥65 Years in France
Nov 19, 2024, 10:30 AM
«
1541
1542
1543
1544
1545
(current)
1546
1547
1548
1549
1550
»